Eurasian Journal Of Medicine And Oncology

SCIE

国际简称：EURASIAN J MED ONCOL 参考译名：欧亚医学与肿瘤学杂志

主要研究方向：Multiple 非预警期刊

《欧亚医学与肿瘤学杂志》(Eurasian Journal Of Medicine And Oncology)是一本由Kare Publishing出版的以Multiple为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

4区中科院分区
Q2 JCR分区
91 年发文量
1.3 IF影响因子
未开放 是否OA
2017 创刊年份
Quarterly 出版周期
English 出版语言

The Eurasian Journal of Medicine and Oncology is an international, peer-reviewed medical journal that focuses on research and progress in the fields of medicine and oncology. This journal aims to provide a platform for researchers, clinical doctors, and students in the fields of medicine and oncology to exchange and share research results, promoting the development of the medical and oncology fields. The magazine covers a wide range of topics, including but not limited to clinical medicine, basic medicine, oncology, pharmacology, pathology, radiology, immunology, genetics, epidemiology, and other disciplines. The journal not only focuses on the prevention, diagnosis, treatment, and rehabilitation of tumors, but also covers other important issues in the medical field, such as chronic disease management, infectious disease prevention and control, and medical technology innovation.

This journal adopts a strict peer review system to ensure that the published research results are scientific and innovative, providing high-quality academic resources for researchers in the fields of medicine and oncology. At the same time, the journal encourages the submission of original research, clinical trials, case reports, reviews, and comments, providing a comprehensive platform for researchers to showcase their research results and academic perspectives.

[ 查看全部 ]

投稿咨询加急咨询

Eurasian Journal Of Medicine And Oncology期刊信息

ISSN：2587-2400
出版语言：English
是否OA：未开放
E-ISSN：2587-196X
出版地区：TURKIYE
是否预警：否
出版商：Kare Publishing
出版周期：Quarterly
创刊时间：2017
开源占比：0.9695
Gold OA文章占比：87.63%
OA被引用占比：0.0070...
出版国人文章占比：0.02
出版撤稿占比：
研究类文章占比：74.73%

Eurasian Journal Of Medicine And Oncology CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

1.1

0.238

0.194

学科类别	分区	排名	百分位
大类：Medicine 小类：Internal Medicine	Q3	130 / 179	27%
大类：Medicine 小类：Oncology	Q4	335 / 428	21%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Eurasian Journal Of Medicine And Oncology中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	4区	ONCOLOGY 肿瘤学 MEDICINE, GENERAL & INTERNAL 医学：内科	4区 4区

Eurasian Journal Of Medicine And Oncology JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：MEDICINE, GENERAL & INTERNAL	ESCI	Q2	160 / 336	52.5
学科：ONCOLOGY	ESCI	Q4	292 / 333	12.5
学科：MEDICINE, GENERAL & INTERNAL	ESCI	Q3	211 / 336	37.35
学科：ONCOLOGY	ESCI	Q4	301 / 333	9.76

Eurasian Journal Of Medicine And Oncology历年数据统计

影响因子

中科院分区

Eurasian Journal Of Medicine And Oncology中国学者发文选摘

1、Risk factor analysis for human epidermal growth factor receptor 2-positive breast cancer patients with brain metastasis: A risk prediction model based on the Surveillance, Epidemiology, and End Results databas
Author: Zhu, Xulong; Liu, Xinmiao; Luo, Ziyu; Wu, Shuhan; Song, Hengtao; Yan, Ke; Wang, Yue; Yang, Liping; Shu, Wenjun; Pan, Kenian; Li, Jianhui

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 173-187. DOI: 10.36922/EJMO025110055
2、Identifying the roles of hub gene in keloid formation using single-cell transcriptomic
Author: Zheng, Xiangbing; Wan, Zhengqiang; Liu, Bing; Yin, Jun; Chen, Cheng; Ma, Yuzhen; Zou, Yong

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 133-147. DOI: 10.36922/EJMO025150098
3、Identification of core symptoms and symptom clusters in primary hepatocellular carcinoma during the intermittent period between transcatheter arterial chemoembolization treatment
Author: Zhang, Jianfeng; Duan, Hongyan; Zhang, Jie; Ji, Mengchen; Shen, Xia; Ni, Yueqin

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 120-132. DOI: 10.36922/EJMO025140083
4、Advances in understanding the mechanism and treatment strategies of radiation myelopath
Author: Yu, Yuhang; Tang, Yukai; Liu, Shengyi; Liu, Limin

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 1-14. DOI: 10.36922/EJMO025100046
5、Regulation of X-linked inhibitor of apoptosis protein by androgen deprivation therapy promotes castration-resistant prostate cancer progressio
Author: Ren, Ke; Gou, Xin; He, Weiyang

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 162-172. DOI: 10.36922/EJMO025160127
6、Targeting PI3K/AKT/mTOR signaling: A promising therapeutic approach for colorectal cance
Author: Qu, Zhaoxia; Pen, Xiaozhen; Lu, Xingjun; Luo, Shunli

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 15-31. DOI: 10.36922/EJMO025190175
7、Causal relationships between mitochondrial DNA copy number and hypertensive disorders in pregnancy: A Mendelian randomization stud
Author: Liu, Lunzhi; Wang, Ao; Yi, Ke

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 100-109. DOI: 10.36922/EJMO025140077
8、Unraveling trends and collaborative dynamics in RAS wild-type colorectal cancer research: A bibliometric analysi
Author: Liu, Kexin; Huang, Xiaoyu; Li, Ping; Wang, Ting; Sun, Ting

Journal: EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY. 2026; Vol. 10, Issue 1, pp. 148-161. DOI: 10.36922/EJMO025140090